This study, to the best of our knowledge, is the largest Brazilian single-center cohort study that evaluates the survival and risk of hepatitis B reactivation and de novo hepatitis B in liver transplant recipients from anti-HBc-positive donors. The gene discussed is KRT88P; the disease is hepatitis B virus infection.